Navigation Links
Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
Date:12/26/2012

New York, New York (PRWEB) December 26, 2012

The runaway biotech bestseller, WIRED, was not only a New York Times and USA Today bestseller, but the bestselling Kindle novel of 2011 in two major categories—science fiction and technothrillers—an unprecedented achievement.

Now, as the WIRED sequel, AMPED, climbs the charts to glowing reviews, the eBook version of WIRED has regained the top spot on Amazon's technothriller list, and is being offered on Amazon for only $5.95. The author of these books, Douglas E. Richards, has been frequently compared to the late Michael Crichton for his ability to weave action, suspense, and well-researched science into riveting page-turners.

Richards has a master's degree in genetic engineering and was a biotechnology executive for many years. "When I wrote WIRED," he explains, "I asked myself the question: what if it were possible to boost human IQ to immeasurable levels for short periods of time? What capabilities might this confer? What changes to attitude and personality? Would this bring out our better angels or unleash our darker sides, causing us to grow ever more drunk with power?"

Both WIRED and AMPED answer these questions in a way that bestselling author Boyd Morrison calls, "action-packed, breathtaking, and mind-blowing."

According to SFRevu founder, Ernest Lilley, "WIRED has a twisty plot, big ideas, and nonstop action and intrigue. It'll have you guessing until the very end."

To learn more about Richards and his work, visit his website at http://www.douglaserichards.co
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
2. UMBC Expands Offerings at The Universities at Shady Grove with Biotechnology Graduate Program
3. Bar Harbor BioTechnology to Offer Direct Sales Starting in 2013; Development of StellARrays™ for C.elegans and Zebrafish Underway
4. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
5. Global Agricultural Biotechnology Industry
6. Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
7. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
8. David Lichtenstein: Biotechnology is Rich Area for Investment
9. Germany Prioritizes Medical Biotechnology with New Initiatives
10. Biomass characterization technology research highlighted in Industrial Biotechnology journal
11. Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today announced a litigation update. ... Verizon Services Corp. et al. , Case No. 1:14-cv-00721-GBL-TCB, ... District of Virginia , the Court ... certain key claims in favor of the Defendants on ...
(Date:7/2/2015)... Memphis, TN (PRWEB) , ... July 02, 2015 ... ... in the development and manufacturing of surgical instruments in Orthopedics, announced today the ... orthopedic contract-manufacturing and the world's largest provider of surgical instruments to the Spine ...
(Date:7/1/2015)... 1, 2015   Decision Resources Group ... of Otezla are its oral administration, alternative mechanism ... by surveyed rheumatologists. Otezla was the first oral ... of active psoriatic arthritis in the ... care includes conventional oral treatments including disease-modifying antirheumatic ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus ... the development of groundbreaking drugs to treat neurodegenerative ... today that Robert G. Miller , M.D., Director ... Sutter Health,s California Pacific Medical Center in San Francisco, ... Association for $1.5 million to help fund a ...
Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4
... June 2 Repligen Corporation (Nasdaq: RGEN ) announced today ... year 2010, on Wednesday, June 9th, 2010 , before the market opens. ... will host a conference call and webcast on the same day at ... update on the Company. , , ...
... SHANGHAI , June 2 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,("China-Biotics", the ... products in China , today announced,it will host a conference call ... 2010 , to discuss the fourth quarter and fiscal year 2010 annual,financial ... , , ...
... SHANGHAI , June 2 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,("China-Biotics", the ... in China , today announced,that its management will present at the Bank ... Tuesday, June 22, 2010 at the Merrill,Lynch Client Service Center in ... ...
Cached Biology Technology:Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2010 Financial Results 2Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2010 Financial Results 3China-Biotics to Report Fourth Quarter and Fiscal Year 2010 Financial Results on June 11 2China-Biotics to Present at Bank of America Merrill Lynch Healthcare Event on June 22 2
(Date:6/11/2015)... , June 11, 2015 Daon, ... announced today that its IdentityX Mobile Authentication Platform ... IDentity Online) Alliance is an industry consortium launched ... standards for simpler, stronger authentication.  In order to ... pass a rigorous series of tests that measure ...
(Date:6/9/2015)... , June 9, 2015   MedNet Solutions ... the entire spectrum of clinical research, will be providing ... technology platform at the 2015 Drug Information Association (DIA) ... on June 15-17.  These presentations will include previews of ... out in the upcoming iMedNet 2015 Feature ...
(Date:6/8/2015)... , June 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... clinical data featuring its Precision Cancer Monitoring SM platform ... Liquid Biopsies conference in San Diego, CA ... Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy ... June 13-16. "We continue to advance our ...
Breaking Biology News(10 mins):Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4
... populating the growing brain, neural stem cells must strike a ... the cells multiply to provide plenty of starting materials ... If the stem cells proliferate too much, they could ... proliferate too little, there may not be enough cells to ...
... / b3c newswire / - KINAXO Biotechnologies GmbH ... service portfolio. KinAffinity provides invaluable information about a ... of interest. It simultaneously determines affinities for native ... overcomes the limitations of traditional biochemical assays that ...
... of researchers from the University of Maryland Center for ... study to forecast the effects of environmental change on ... by a $620,000 grant from the National Science Foundation, ... Preserve near Alexandria, Virginia. "Freshwater marshes are integral ...
Cached Biology News:UNC study pinpoints gene controlling number of brain cells 2KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue 2